Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fang Tong

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
NPJ Science of Food|May 19, 2026
Unveiling the improvement mechanisms of moist-heat and hot-air treatments on the flavor of Panax quinquefoliusHong-Juan Hou, Wen-Han Pei, Rui-Bo Sun, et al.
Leukemia & Lymphoma|October 6, 2025
Venetoclax plus hypomethylating agents versus priming regimen as the first-line therapy for newly diagnosed acute myeloid leukemia with myelodysplasia-related changes: a propensity score-matched analysisYuan-Hong Huang, Fang-Tong Liu, Chao-Ling Wan, et al.
Cancer|November 7, 2025
A phase 2 trial of a "sandwich" strategy: Sequential CD22/CD19 chimeric antigen receptor T-cells therapy combined with autologous hematopoietic stem cell transplantation in patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemiaChong-Sheng Qian, Zi-Hao Wang, Zheng Li, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
NPJ Science of Food|May 19, 2026
Unveiling the improvement mechanisms of moist-heat and hot-air treatments on the flavor of Panax quinquefoliusHong-Juan Hou, Wen-Han Pei, Rui-Bo Sun, et al.
Leukemia & Lymphoma|October 6, 2025
Venetoclax plus hypomethylating agents versus priming regimen as the first-line therapy for newly diagnosed acute myeloid leukemia with myelodysplasia-related changes: a propensity score-matched analysisYuan-Hong Huang, Fang-Tong Liu, Chao-Ling Wan, et al.
Cancer|November 7, 2025
A phase 2 trial of a "sandwich" strategy: Sequential CD22/CD19 chimeric antigen receptor T-cells therapy combined with autologous hematopoietic stem cell transplantation in patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemiaChong-Sheng Qian, Zi-Hao Wang, Zheng Li, et al.
Pageof 13